SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-06-005034
Filing Date
2006-08-14
Accepted
2006-08-14 13:55:20
Documents
8
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 BOSTON LIFE SCIENCES b61579ble10vq.htm 10-Q 357464
2 EX-10.1 EXCLUSIVE LICENSE AGREEMENT (BENOWITZ) b61579blexv10w1.txt EX-10.1 147031
3 EX-10.2 EXCLUSIVE LICENSE AGREEMENT (HE) b61579blexv10w2.txt EX-10.2 142426
4 EX-10.3 PROMISSORY NOTE (UNSECURED) IN FAVOR OF ROBERT GIPSON DATED AUGUST 8, 20 b61579blexv10w3.txt EX-10.3 18739
5 EX-31.1 SECTION 302 CERTIFICATION OF C.E.O. b61579blexv31w1.htm EX-31.1 7966
6 EX-31.2 SECTION 302 CERTIFICATION OF C.F.O. b61579blexv31w2.htm EX-31.2 8044
7 EX-32.1 SECTION 906 CERTIFICATION OF C.E.O. b61579blexv32w1.htm EX-32.1 3018
8 EX-32.2 SECTION 906 CERTIFICATION OF C.F.O. b61579blexv32w2.htm EX-32.2 3101
  Complete submission text file 0000950135-06-005034.txt   689459
Mailing Address 20 NEWBURY STREET 5TH FLOOR BOSTON MA 02116
Business Address 20 NEWBURY STREET 5TH FLOOR BOSTON MA 02116 6174250200
BOSTON LIFE SCIENCES INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-06533 | Film No.: 061028806
SIC: 2834 Pharmaceutical Preparations